More precisely, an immune landscape study performed scRNA-seq analysis in peripheral blood mononuclear cells (PBMCs) in patients with mild or severe COVID19 and reported that IFN-I responses co-occurred with inflammatory responses driven by TFN- and IL1-driven cytokines in patients with severe COVID19 compared to patients with mild COVID19 [42]. The gene discussed is IL1B; the disease is COVID-19.